Alkem Laboratories looking to tap domestic, international markets for growth

14 Aug 2017 Evaluate

Alkem Laboratories is looking to tap domestic as well as international markets, for growth going forward. The company is looking to consolidate its market leading position in its established therapy areas of anti-infectives, gastro-intestinal, pain management and vitamins, minerals & nutrients.

In the domestic market, the company plans to consolidate presence in the segments it is in and is aiming to build base in the emerging therapy areas and over the counter (OTC) segment. The Mumbai-based firm is also looking at building base in the emerging therapy areas of cardiac, anti-diabetes, CNS and derma (skin) by leveraging on its core strengths.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Alkem Laboratories Share Price

4906.35 -92.65 (-1.85%)
28-Mar-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1620.50
Dr. Reddys Lab 6171.85
Cipla 1494.65
Zydus Lifesciences 1013.75
Lupin 1617.85
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.